Balazs Gulyas

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Professor i nuklearmedicin, särskilt positronemissionstomografi (PET).

Artiklar

Article: JOURNAL OF NUCLEAR MEDICINE. 2019;60(12):1818-1824

Performance Evaluation of a High-Resolution Nonhuman Primate PET/CT System.

Sarnyai Z; Nagy K; Patay G; Molnár M; Rosenqvist G; Tóth M; Takano A; Gulyás B; Major P; Halldin C; Varrone A
Article: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2019;29(16):2270-2274

Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging.

Nag S; Krasikova R; Airaksinen AJ; Arakawa R; Petukhovd M; Gulyas B
Article: SCIENCE TRANSLATIONAL MEDICINE. 2019;11(502):eaan5662

The gut microbiota influences skeletal muscle mass and function in mice.

Lahiri S; Kim H; Garcia-Perez I; Reza MM; Martin KA; Kundu P; Cox LM; Selkrig J; Posma JM; Zhang H; Padmanabhan P; Moret C; Gulyás B; Blaser MJ; Auwerx J; Holmes E; Nicholson J; Wahli W; Pettersson S
Article: BRAIN RESEARCH. 2019;1711:140-145

In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659.

Svedberg MM; Varnäs K; Varrone A; Mitsios N; Mulder J; Gulyás B; Beaumont V; Munoz-Sanjuan I; Zaleska MM; Schmidt CJ; Halldin C; Mrzljak L
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37(6):2062-2075

An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter.

Kannan P; Schain M; Kretzschmar WW; Weidner L; Mitsios N; Gulyás B; Blom H; Gottesman MM; Innis RB; Hall MD; Mulder J
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2017;214(3):699-717

27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation.

Ismail M-A; Mateos L; Maioli S; Merino-Serrais P; Ali Z; Lodeiro M; Westman E; Leitersdorf E; Gulyás B; Olof-Wahlund L; Winblad B; Savitcheva I; Björkhem I; Cedazo-Mínguez A
Article: SCIENTIFIC REPORTS. 2017;7:42014

The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms.

Kovács T; Billes V; Komlós M; Hotzi B; Manzéger A; Tarnóci A; Papp D; Szikszai F; Szinyákovics J; Rácz Á; Noszál B; Veszelka S; Walter FR; Deli MA; Hackler L; Alfoldi R; Huzian O; Puskas LG; Liliom H; Tárnok K; Schlett K; Borsy A; Welker E; Kovács AL; Pádár Z; Erdős A; Legradi A; Bjelik A; Gulya K; Gulyás B; Vellai T
Article: AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2017;7(6):246-254

Simplified estimation of binding parameters based on image-derived reference tissue models for dopamine transporter bindings in non-human primates using [18F]FE-PE2I and PET.

Odano I; Varrone A; Hosoya T; Sakaguchi K; Gulyás B; Padmanabhan P; Ghosh KK; Yang C-T; Guenther I; Wang Z; Serrano R; Chimon NG; Halldin C
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2016;43(12):2255-2262

Guidelines to PET measurements of the target occupancy in the brain for drug development.

Takano A; Varrone A; Gulyás B; Salvadori P; Gee A; Windhorst A; Vercouillie J; Bormans G; Lammertsma AA; Halldin C
Article: SYNAPSE. 2016;70(6):253-263

Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11 C]T-773 in nonhuman primates.

Takano A; Stepanov V; Nakao R; Amini N; Gulyás B; Kimura H; Halldin C
Article: JOURNAL OF HUNTINGTON'S DISEASE. 2016;5(2):133-147

AUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease.

Billes V; Kovács T; Hotzi B; Manzéger A; Tagscherer K; Komlós M; Tarnóci A; Pádár Z; Erdős A; Bjelik A; Legradi A; Gulya K; Gulyás B; Vellai T
Article: BRAIN STRUCTURE & FUNCTION. 2016;221(3):1279-1290

Acute neuroinflammation in a clinically relevant focal cortical ischemic stroke model in rat: longitudinal positron emission tomography and immunofluorescent tracking.

Tóth M; Little P; Arnberg F; Häggkvist J; Mulder J; Halldin C; Gulyás B; Holmin S
Article: AUTOPHAGY. 2016;12(2):273-286

AUTEN-67, an autophagy-enhancing drug candidate with potent antiaging and neuroprotective effects.

Papp D; Kovács T; Billes V; Varga M; Tarnóci A; Hackler L; Puskás LG; Liliom H; Tárnok K; Schlett K; Borsy A; Pádár Z; Kovács AL; Hegedűs K; Juhász G; Komlós M; Erdős A; Gulyás B; Vellai T
Article: NEUROPHARMACOLOGY. 2016;101:519-530

A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates.

Hjorth S; Karlsson C; Jucaite A; Varnäs K; Wählby Hamrén U; Johnström P; Gulyás B; Donohue SR; Pike VW; Halldin C; Farde L
Article: EJNMMI PHYSICS. 2015;2(Suppl 1):A90

Biocompatible branched copolymer nanoparticles prepared by RAFT polymerization as MRI/PET bimodal tracers.

Yang C-T; Tao H; Jackson AW; Chandrasekharan P; Padmanabhan P; Gulyás B; Halldin C
Article: BRAIN STRUCTURE & FUNCTION. 2015;220(5):3043-3051

Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain.

Gulyás B; Sovago J; Gomez-Mancilla B; Jia Z; Szigeti C; Gulya K; Schumacher M; Maguire RP; Gasparini F; Halldin C
Article: MOLECULAR IMAGING AND BIOLOGY. 2015;17(4):445-449

Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [(11)C]T-773.

Tóth M; Häggkvist J; Stepanov V; Takano A; Nakao R; Amini N; Miura S; Kimura H; Taniguchi T; Gulyás B; Halldin C
Article: SYNAPSE. 2015;69(7):345-355

Evaluation of a novel PDE10A PET radioligand, [(11) C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography.

Takano A; Stepanov V; Gulyás B; Nakao R; Amini N; Miura S; Kimura H; Taniguchi T; Halldin C
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2015;42(7):1119-1132

Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.

Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
Article: PLOS ONE. 2015;10(5):e0125917

Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation.

Tóth M; Doorduin J; Häggkvist J; Varrone A; Amini N; Halldin C; Gulyás B
Article: MOLECULAR IMAGING AND BIOLOGY. 2014;16(2):173-179

Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primates.

Schou M; Varnäs K; Sandell J; Johnström P; Cselenyi Z; Svensson S; Nakao R; Amini N; Bergman L; Sumic A; Gulyas B; Lindström-Böö E; Halldin C; Farde L
Article: SYNAPSE. 2014;68(3):89-97

Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study.

Takano A; Gulyás B; Varnäs K; Little PB; Noerregaard PK; Jensen NO; Elling CE; Halldin C
Article: BIOGRAPHICAL MEMOIRS OF FELLOWS OF THE ROYAL SOCIETY. ROYAL SOCIETY (GREAT BRITAIN). 2013;59:383-406

JÁNOS SZENTÁGOTHAI. 31 October 1912 - 8 September 1994: Elected ForMemRs 20 April 1978.

Gulyás B; Somogyi P
Article: JOURNAL OF NUCLEAR MEDICINE. 2013;54(10):1825-1832

Performance evaluation of the small-animal nanoScan PET/MRI system.

Nagy K; Tóth M; Major P; Patay G; Egri G; Häggkvist J; Varrone A; Farde L; Halldin C; Gulyás B
Article: SYNAPSE. 2013;67(9):586-595

The dopamine D₁ receptor agonist (S)-[¹¹C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration--a positron emission tomography examination in the monkey brain.

Finnema SJ; Bang-Andersen B; Jørgensen M; Christoffersen CT; Gulyás B; Wikström HV; Farde L; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2013;40(6):747-754

Radiosynthesis and evaluation of new α1-adrenoceptor antagonists as PET radioligands for brain imaging.

Airaksinen AJ; Finnema SJ; Balle T; Varnäs K; Bang-Andersen B; Gulyás B; Farde L; Halldin C
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;40(6):921-931

In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients.

Varrone A; Mattsson P; Forsberg A; Takano A; Nag S; Gulyás B; Borg J; Boellaard R; Al-Tawil N; Eriksdotter M; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Lammertsma AA; Halldin C
Article: SYNAPSE. 2013;67(5):258-264

Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.

Tóth M; Varrone A; Steiger C; Laszlovszky I; Horváth A; Kiss B; Gyertyán I; Adham N; Halldin C; Gulyás B
Article: EJNMMI RESEARCH. 2013;3(1):30

In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.

Takano A; Piehl F; Hillert J; Varrone A; Nag S; Gulyás B; Stenkrona P; Villemagne VL; Rowe CC; Macdonell R; Tawil NA; Kucinski T; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2013;40(3):410-414

Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate.

Schou M; Varnäs K; Jucaite A; Gulyás B; Halldin C; Farde L
Article: BRAIN RESEARCH BULLETIN. 2013;91:46-51

In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse.

Máthé D; Horváth I; Szigeti K; Donohue SR; Pike VW; Jia Z; Ledent C; Palkovits M; Freund TF; Halldin C; Gulyás B
Article: BIOORGANIC & MEDICINAL CHEMISTRY. 2013;21(1):186-195

Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity.

Nag S; Kettschau G; Heinrich T; Varrone A; Lehmann L; Gulyas B; Thiele A; Keller É; Halldin C
Article: JOURNAL OF NUCLEAR MEDICINE. 2012;53(11):1794-1801

Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.

Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2012;320(1-2):110-117

Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine.

Gulyás B; Tóth M; Schain M; Airaksinen A; Vas A; Kostulas K; Lindström P; Hillert J; Halldin C
Article: EJNMMI RESEARCH. 2012;2(1):37

Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[11 C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([11 C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1.

Fuchigami T; Takano A; Gulyás B; Jia Z; Finnema SJ; Andersson JD; Nakao R; Magata Y; Haratake M; Nakayama M; Halldin C
Article: ACTA NEUROLOGICA SCANDINAVICA. 2012;125(6):373-381

Correlation between crossed cerebellar diaschisis and clinical neurological scales.

Szilágyi G; Vas A; Kerényi L; Nagy Z; Csiba L; Gulyás B
Article: BRAIN RESEARCH. 2012;1453:56-63

Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.

Farkas S; Nagy K; Jia Z; Hortobágyi T; Varrone A; Halldin C; Csiba L; Gulyás B
Article: BIOORGANIC & MEDICINAL CHEMISTRY. 2012;20(9):3065-3071

Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).

Nag S; Lehmann L; Kettschau G; Heinrich T; Thiele A; Varrone A; Gulyas B; Halldin C
Article: BRAIN RESEARCH BULLETIN. 2012;87(6):504-510

The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.

Farkas S; Nagy K; Jia Z; Harkany T; Palkovits M; Donohou SR; Pike VW; Halldin C; Máthé D; Csiba L; Gulyás B
Article: NUCLEAR MEDICINE AND BIOLOGY. 2012;39(3):315-323

Fluorine-18 labeling of three novel D-peptides by conjugation with N-succinimidyl-4-[18F]fluorobenzoate and preliminary examination by postmortem whole-hemisphere human brain autoradiography.

Jahan M; Nag S; Krasikova R; Weber U; Muhs A; Pfeifer A; Spenger C; Willbold D; Gulyás B; Halldin C
Article: NEUROCHEMISTRY INTERNATIONAL. 2012;60(3):286-291

[¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease.

Farkas S; Nagy K; Palkovits M; Kovács GG; Jia Z; Donohue S; Pike V; Halldin C; Máthé D; Harkany T; Gulyás B; Csiba L
Article: NUCLEAR MEDICINE AND BIOLOGY. 2012;39(2):295-303

Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studies.

Varrone A; Gulyás B; Takano A; Stabin MG; Jonsson C; Halldin C
Article: CURRENT RADIOPHARMACEUTICALS. 2012;5(1):19-28

Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine.

Gulyas B; Toth M; Vas A; Shchukin E; Kostulas K; Hillert J; Halldin C
Article: PLOS ONE. 2012;7(7):e41457

Development of a small D-enantiomeric Alzheimer's amyloid-β binding peptide ligand for future in vivo imaging applications.

Funke SA; Bartnik D; Glück JM; Piorkowska K; Wiesehan K; Weber U; Gulyas B; Halldin C; Pfeifer A; Spenger C; Muhs A; Willbold D
Article: NEUROCHEMISTRY INTERNATIONAL. 2012;60(2):153-162

Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients.

Gulyás B; Spenger C; Beliczai Z; Gulya K; Kása P; Jahan M; Jia Z; Weber U; Pfeifer A; Muhs A; Willbold D; Halldin C
Article: PSYCHOPHARMACOLOGY. 2011;218(3):579-587

Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography.

Seneca N; Finnema SJ; Laszlovszky I; Kiss B; Horváth A; Pásztor G; Kapás M; Gyertyán I; Farkas S; Innis RB; Halldin C; Gulyás B
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2011;38(11):2058-2065

Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study.

Takano A; Gulyás B; Varrone A; Karlsson P; Sjoholm N; Larsson S; Jonsson C; Odh R; Sparks R; Al Tawil N; Hoffmann A; Zimmermann T; Thiele A; Halldin C
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2011;54(20):7023-7029

Synthesis of three novel fluorine-18 labeled analogues of L-deprenyl for positron emission tomography (PET) studies of monoamine oxidase B (MAO-B).

Nag S; Lehmann L; Heinrich T; Thiele A; Kettschau G; Nakao R; Gulyás B; Halldin C
Article: JOURNAL OF NUCLEAR MEDICINE. 2011;52(8):1313-1321

Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.

Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
Article: PSYCHOPHARMACOLOGY. 2011;216(2):279-286

NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo.

Takano A; Nag S; Gulyás B; Halldin C; Farde L
Article: NEUROIMAGE. 2011;56(3):1111-1121

Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.

Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2011;38(2):261-272

Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds.

Andersson JD; Pierson ME; Finnema SJ; Gulyás B; Heys R; Elmore CS; Farde L; Halldin C
Article: NEUROCHEMISTRY INTERNATIONAL. 2011;58(1):60-68

Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.

Gulyás B; Pavlova E; Kása P; Gulya K; Bakota L; Várszegi S; Keller E; Horváth MC; Nag S; Hermecz I; Magyar K; Halldin C
Article: JOURNAL OF NUCLEAR MEDICINE. 2011;52(1):132-139

Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.

Varrone A; Tóth M; Steiger C; Takano A; Guilloteau D; Ichise M; Gulyás B; Halldin C
Article: SYNAPSE. 2010;64(10):733-741

Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys.

Andersson JD; Varnäs K; Cselényi Z; Gulyás B; Wensbo D; Finnema SJ; Swahn B-M; Svensson S; Nyberg S; Farde L; Halldin C
Article: SYNAPSE. 2010;64(7):573-577

Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain.

Finnema SJ; Varrone A; Hwang TJ; Gulyás B; Pierson ME; Halldin C; Farde L
Article: NEUROCHEMISTRY INTERNATIONAL. 2010;56(6-7):789-798

The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study.

Gulyás B; Brockschnieder D; Nag S; Pavlova E; Kása P; Beliczai Z; Légrádi A; Gulya K; Thiele A; Dyrks T; Halldin C
Article: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2009;19(21):6209-6212

Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.

Donohue SR; Varnäs K; Jia Z; Gulyás B; Pike VW; Halldin C
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2009;36(11):1885-1891

Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER.

Takano A; Gulyás B; Varrone A; Halldin C
Article: SYNAPSE. 2009;63(10):871-880

In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.

Varrone A; Steiger C; Schou M; Takano A; Finnema SJ; Guilloteau D; Gulyás B; Halldin C
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2009;36(8):1308-1314

Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2).

Takano A; Gulyás B; Varrone A; Maguire RP; Halldin C
Article: SYNAPSE. 2009;63(5):378-389

Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.

Finnema SJ; Halldin C; Bang-Andersen B; Gulyás B; Bundgaard C; Wikström HV; Farde L
Article: NEUROCHEMISTRY INTERNATIONAL. 2009;54(1):28-36

A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.

Gulyás B; Makkai B; Kása P; Gulya K; Bakota L; Várszegi S; Beliczai Z; Andersson J; Csiba L; Thiele A; Dyrks T; Suhara T; Suzuki K; Higuchi M; Halldin C
Article: SYNAPSE. 2009;63(1):22-30

Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.

Finnema SJ; Donohue SR; Zoghbi SS; Brown AK; Gulyás B; Innis RB; Halldin C; Pike VW
Article: MOLECULAR IMAGING AND BIOLOGY. 2009;11(1):23-30

Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.

Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow J-S; Hong J; Andrée BA; Gulyás B; Farde L; Innis RB; Pike VW; Halldin C
Article: NEUROCHEMISTRY INTERNATIONAL. 2008;53(6-8):181-183

Immunohistoblot analysis on whole human hemispheres from normal and Alzheimer diseased brains.

Beliczai Z; Varszegi S; Gulyas B; Halldin C; Kasa P; Gulya K
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2008;51(18):5608-5616

Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.

Donohue SR; Pike VW; Finnema SJ; Truong P; Andersson J; Gulyás B; Halldin C
Article: NEUROIMAGE. 2008;42(2):474-482

Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2.

Takano A; Varrone A; Gulyás B; Karlsson P; Tauscher J; Halldin C
Article: BIOORGANIC & MEDICINAL CHEMISTRY. 2008;16(13):6467-6473

[11C]cyclopropyl-FLB 457: a PET radioligand for low densities of dopamine D2 receptors.

Airaksinen AJ; Nag S; Finnema SJ; Mukherjee J; Chattopadhyay S; Gulyás B; Farde L; Halldin C
Article: NEUROIMAGE. 2008;41(3):1075-1085

[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.

Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee C-M; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008;35(3):630-636

Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study.

Takano A; Halldin C; Varrone A; Karlsson P; Sjöholm N; Stubbs JB; Schou M; Airaksinen AJ; Tauscher J; Gulyás B
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2008;264(1-2):9-17

Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.

Vas A; Shchukin Y; Karrenbauer VD; Cselényi Z; Kostulas K; Hillert J; Savic I; Takano A; Halldin C; Gulyás B
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008;35(1):153-157

Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2.

Takano A; Gulyás B; Varrone A; Karlsson P; Schou M; Airaksinen AJ; Vandenhende F; Tauscher J; Halldin C
Article: BIOORGANIC & MEDICINAL CHEMISTRY. 2007;15(2):616-625

Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.

Schou M; Pike VW; Sóvágó J; Gulyás B; Gallagher PT; Dobson DR; Walter MW; Rudyk H; Farde L; Halldin C
Article: BULLETIN ET MEMOIRES DE L'ACADEMIE ROYALE DE MEDECINE DE BELGIQUE. 2007;162(3-4):225-237

The receptor fingerprint of the human brain and its changes during life.

Gulyás B
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2006;49(11):1007-1019

Synthesis and PET evaluation of (R)-[S-methyl-¹¹C]thionisoxetine, a candidate radioligand for imaging brain norepinephrine transporters

Schou M; Pike VW; Varrone A; Gulyas B; Farde L; Halldin C
Article: NEUROIMAGE. 2006;32(4):1690-1708

A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635.

Cselényi Z; Olsson H; Halldin C; Gulyás B; Farde L
Article: PSYCHOPHARMACOLOGY. 2006;188(1):119-127

Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.

Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2006;246(1-2):85-94

Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.

Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
Article: SYNAPSE. 2006;59(5):260-269

Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.

Seneca N; Finnema SJ; Farde L; Gulyás B; Wikström HV; Halldin C; Innis RB
Article: NEUROCHEMICAL RESEARCH. 2006;31(2):157-166

Continuous monitoring of post mortem temperature changes in the human brain.

Gulyás B; Dobai J; Szilágyi G; Csécsei G; Székely G
Article: MOLECULAR IMAGING AND BIOLOGY. 2006;8(1):1-8

Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram.

Schou M; Sóvágó J; Pike VW; Gulyás B; Bøgesø KP; Farde L; Halldin C
Article: SYNAPSE. 2005;58(3):173-183

[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.

Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
Article: BRAIN RESEARCH BULLETIN. 2005;67(3):219-224

Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756.

Sóvágó J; Farde L; Halldin C; Schukin E; Schou M; Laszlovszky I; Kiss B; Gulyás B
Article: NUCLEAR MEDICINE COMMUNICATIONS. 2005;26(8):695-700

Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates.

Seneca N; Andree B; Sjoholm N; Schou M; Pauli S; Mozley PD; Stubbs JB; Liow J-S; Sovago J; Gulyás B; Innis R; Halldin C
Article: EUROPEAN JOURNAL OF NEUROSCIENCE. 2005;22(1):65-71

Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.

Sóvágó J; Makkai B; Gulyás B; Hall H
Article: NUCLEAR MEDICINE AND BIOLOGY. 2005;32(4):353-360

A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.

Finnema SJ; Seneca N; Farde L; Shchukin E; Sóvágó J; Gulyás B; Wikström HV; Innis RB; Neumeyer JL; Halldin C
Article: NEUROSCIENCE LETTERS. 2005;375(1):33-36

Feature uncertainty: a novel test to probe prefrontal dysfunction in unaffected siblings of schizophrenia patients.

Kéri S; Gulyás B; Benedek G; Janka Z
Article: BIOORGANIC & MEDICINAL CHEMISTRY. 2005;13(3):883-893

N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists.

Marchais-Oberwinkler S; Nowicki B; Pike VW; Halldin C; Sandell J; Chou Y-H; Gulyas B; Brennum LT; Farde L; Wikström HV
Article: NUCLEAR MEDICINE AND BIOLOGY. 2005;32(2):109-116

Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography.

Ryzhikov NN; Seneca N; Krasikova RN; Gomzina NA; Shchukin E; Fedorova OS; Vassiliev DA; Gulyás B; Hall H; Savic I; Halldin C
Article: NEUROCHEMISTRY INTERNATIONAL. 2004;45(5):773-781

Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data.

Cselényi Z; Lundberg J; Halldin C; Farde L; Gulyás B
Article: NEUROCHEMISTRY INTERNATIONAL. 2004;45(5):609-617

Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.

Sóvágó J; Farde L; Halldin C; Langer O; Laszlovszky I; Kiss B; Gulyás B
Article: SYNAPSE. 2004;53(2):57-67

PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.

Schou M; Halldin C; Sóvágó J; Pike VW; Hall H; Gulyás B; Mozley PD; Dobson D; Shchukin E; Innis RB; Farde L
Article: NEUROREPORT. 2004;15(8):1275-1277

Smelling human sex hormone-like compounds affects face gender judgment of men.

Kovács G; Gulyás B; Savic I; Perrett DI; Cornwell RE; Little AC; Jones BC; Burt DM; Gál V; Vidnyánszky Z
Article: NEUROCHEMISTRY INTERNATIONAL. 2004;44(8):595-600

The putative pheromone androstadienone activates cortical fields in the human brain related to social cognition.

Gulyás B; Kéri S; O'Sullivan BT; Decety J; Roland PE
Article: NEUROLOGY. 2004;62(8):1343-1351

Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.

Savic I; Lindström P; Gulyás B; Halldin C; Andrée B; Farde L
Article: HUMAN BRAIN MAPPING. 2004;21(1):26-33

Feature uncertainty activates anterior cingulate cortex.

Kéri S; Decety J; Roland PE; Gulyás B
Article: ORVOSI HETILAP. 2003;144(46):2271-2276

[Human positron emission tomography with oral 11C-vinpocetine].

Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
Article: NUCLEAR MEDICINE AND BIOLOGY. 2003;30(7):707-714

Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.

Schou M; Halldin C; Sóvágó J; Pike VW; Gulyás B; Mozley PD; Johnson DP; Hall H; Innis RB; Farde L
Article: ACTA NEUROLOGICA SCANDINAVICA. 2002;106(6):325-332

PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.

Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L
Article: NUCLEAR MEDICINE AND BIOLOGY. 2002;29(7):753-759

Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study.

Gulyás B; Vas A; Halldin C; Sóvágó J; Sandell J; Olsson H; Fredriksson A; Stone-Elander S; Farde L
Article: NEUROIMAGE. 2002;17(1):47-60

Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457.

Cselényi Z; Olsson H; Farde L; Gulyás B
Article: HUMAN BRAIN MAPPING. 2002;17(1):17-27

Odorant differentiated pattern of cerebral activation: comparison of acetone and vanillin.

Savic I; Gulyás B; Berglund H
Article: NUCLEAR MEDICINE AND BIOLOGY. 2002;29(6):651-656

PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter.

Sandell J; Halldin C; Sovago J; Chou Y-H; Gulyás B; Yu M; Emond P; Någren K; Guilloteau D; Farde L
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2002;29(8):1031-1038

Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.

Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L
Article: EXPERIMENTAL BRAIN RESEARCH. 2002;143(1):1-10

Perceptual segregation of overlapping shapes activates posterior extrastriate visual cortex in man.

Larsson J; Amunts K; Gulyás B; Malikovic A; Zilles K; Roland PE
Article: BIOLOGIA FUTURA. 2002;53(1-2):59-66

Autoradiographic evaluation of [11C]vinpocetine binding in the human postmortem brain.

Hall H; Varnäs K; Sandell J; Halldin C; Farde L; Vas A; Kárpáti E; Gulyás B
Article: NEURON. 2001;31(4):661-668

Smelling of odorous sex hormone-like compounds causes sex-differentiated hypothalamic activations in humans.

Savic I; Berglund H; Gulyas B; Roland P
Article: NEUROREPORT. 2001;12(9):2027-2033

Brain activation during odor perception in males and females.

Bengtsson S; Berglund H; Gulyas B; Cohen E; Savic I
Article: ORVOSI HETILAP. 2001;142(9):443-449

[The effect of a single-dose intravenous vinpocetine on brain metabolism in patients with ischemic stroke].

Gulyás B; Bönöczk P; Vas A; Csiba L; Bereczki D; Boros I; Szakáll S; Balkay L; Emri M; Fekete I; Galuska L; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Trón L
Article: BRAIN RESEARCH BULLETIN. 2001;54(3):319-328

Neural networks for internal reading and visual imagery of reading: a PET study.

Gulyás B
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2000;43(11):1069-1074

Radiochemical labelling of the dopamine D₃ receptor ligand RGH-1756

Langer O; Gulyás B; Sandell J; Laszlovszky I; Kiss B; Domány G; Acs T; Farde L; Halldin C
Article: HUMAN BRAIN MAPPING. 2000;11(2):104-116

Visual exploration of form and position with identical stimuli: functional anatomy with PET.

Vidnyánszky Z; Gulyás B; Roland PE
Article: NEUROREPORT. 2000;11(13):2861-2866

PET shows that odors are processed both ipsilaterally and contralaterally to the stimulated nostril.

Savic I; Gulyas B
Article: NEUROLOGY. 2000;55(4):544-548

Cerebral blood flow and glucose metabolism in mitochondrial disorders.

Molnár MJ; Valikovics A; Molnár S; Trón L; Diószeghy P; Mechler F; Gulyás B
Article: NEURON. 2000;26(3):735-745

Olfactory functions are mediated by parallel and hierarchical processing.

Savic I; Gulyas B; Larsson M; Roland P
Article: EUROPEAN JOURNAL OF NEUROSCIENCE. 1999;11(11):4024-4036

Neuronal correlates of real and illusory contour perception: functional anatomy with PET.

Larsson J; Amunts K; Gulyás B; Malikovic A; Zilles K; Roland PE
Article: JOURNAL OF NEUROIMAGING. 1999;9(4):217-222

Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey.

Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöck P; Paróczai M; Farde L
Article: ORVOSI HETILAP. 1999;140(30):1687-1691

[Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].

Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
Article: NEUROREPORT. 1999;10(14):I-III

Functional neuroimaging-functional neuropathology:: The quest for validation

Gulyás B; Lestár M
Article: JOURNAL OF NEUROIMAGING. 1998;8(4):197-204

Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.

Szakáll S; Boros I; Balkay L; Emri M; Fekete I; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Galuska L; Trón L; Bereczki D; Csiba L; Gulyás B
Article: ACTA NEUROLOGICA SCANDINAVICA. 1998;97(5):279-286

Regional increases in [11C]flumazenil binding after epilepsy surgery.

Savic I; Blomqvist G; Halldin C; Litton JE; Gulyas B
Article: HUMAN BRAIN MAPPING. 1998;6(3):115-127

Visual form discrimination from texture cues: a PET study.

Gulyás B; Cowey A; Heywood CA; Popplewell D; Roland PE
Article: EUROPEAN JOURNAL OF NEUROSCIENCE. 1996;8(11):2232-2235

Assumptions and validations of statistical tests for functional neuroimaging.

Roland PE; Gulyás B
Article: NEUROREPORT. 1996;7(2):463-468

Cortical representation of self-paced finger movement.

Larsson J; Gulyás B; Roland PE
Article: SCIENCE. 1996;271(5248):512-515

Activation by attention of the human reticular formation and thalamic intralaminar nuclei.

Kinomura S; Larsson J; Gulyás B; Roland PE
Article: BIOLOGIA FUTURA. 1996;47(1-4):157-172

Regional glucose metabolic rates in the human brain: a PET study.

Gulyás B; Trón L; Balkay L; Emri M; Molnár T; Tóth G; Marian T
Article: CEREBRAL CORTEX. 1995;5(1):79-93

Visual memory, visual imagery, and visual recognition of large field patterns by the human brain: functional anatomy by positron emission tomography.

Roland PE; Gulyás B
Article: HUMAN BRAIN MAPPING. 1995;3(2):133-152

Cortical fields participating in spatial frequency and orientation discrimination functional anatomy by positron emission tomography

Gulyas B; Roland PE
Visa fler

Alla övriga publikationer

Review: JOURNAL OF NEUROSCIENCE METHODS. 2020;331:108525

Blood brain barrier: A tissue engineered microfluidic chip.

Musafargani S; Mishra S; Gulyás M; Mahalakshmi P; Archunan G; Padmanabhan P; Gulyás B
Review: THERANOSTICS. 2018;8(22):6210-6232

PET-MR and SPECT-MR multimodality probes: Development and challenges.

Yang C-T; Ghosh KK; Padmanabhan P; Langer O; Liu J; Eng DNC; Halldin C; Gulyás B
Review: QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2012;56(2):173-190

New PET radiopharmaceuticals beyond FDG for brain tumor imaging.

Gulyás B; Halldin C
Meeting abstract: NEUROIMAGE. 2010;52:S118-S119

Quantification of [18F]LBT-999 binding to the dopamine transporter in the rhesus monkey brain with the HRRT system

Varrone A; Toth M; Stepanov V; Nakao R; Gulyas B; Emond P; Deloye JB; Vercouillie J; Halldin C; Guilloteau D
Meeting abstract: NEUROIMAGE. 2010;52:S121

Synthesis of three F-18 labeled analogues of 1-deprenyl for PET Studies of monoamine oxidase B

Nag S; Lehmann L; Kettschau G; Heinrich T; Brumby T; Thiele A; Varrone A; Gulyas B; Halldin C
Meeting abstract: NEUROIMAGE. 2010;52:S168

Kinetic analysis and quantification of the dopamine transporter in the non-human primate brain with [11C]PE2I and [18F]FE-PE2I

Varrone A; Toth M; Steiger C; Takano A; Guilloteau D; Ichise M; Gulyas B; Halldin C
Meeting abstract: NEUROIMAGE. 2010;52:S106

Clomipramine and the active metabolite, desmethylclomipramine, occupy NET in non-human primate measured by PET

Takano A; Gulyas B; Halldin C
Meeting abstract: NEUROIMAGE. 2010;52:S100

PET studies in cynomolgous monkeys and whole hemisphere post mortem autoradiographic studies in human brain slices with the dopamine D2/D3 receptor ligand 11C-cariprazine

Toth M; Varrone A; Jia Z; Horvath A; Laszlovszky I; Kiss B; Halldin C; Gulyas B
Meeting abstract: NEUROIMAGE. 2010;52:S80

GSK588045 occupancy of brain 5-HT1A receptors examined using [11C]WAY100635 PET

van der Aart J; Comley R; Gulyas B; Garnier M; Petrone M; Iavarone L; Halldin C; Rabiner E
Meeting abstract: NEUROIMAGE. 2010;52:S61-S62

Amphetamine decreases binding of the novel alpha2C-adrenoreceptor radioligand [11C]ORM-13070 in monkey brain

Finnema SJ; Varnas K; Stepanov V; Varrone A; Gulyas B; Arponen E; Helin S; Solin O; Haaparanta M; Sallinen J; Ingman K; Scheinin M; Farde L; Halldin C
Meeting abstract: SCHIZOPHRENIA RESEARCH. 2010;117(2-3):258-259

BRAIN DISTRIBUTION AND BINDING OF [¹¹C]CARIPRAZINE: IN VIVO PET STUDIES IN NON-HUMAN PRIMATES AND WHOLE HEMISPHERE POSTMORTEM AUTORADIOGRAPHIC STUDIES IN HUMAN BRAIN SLICES

Gulyas B; Toth M; Varrone A; Horvath A; Laszlovszky I; Kiss B; Halldin C
Published conference paper: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2009;36(10):1639-1650

Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

Varrone A; Sjöholm N; Eriksson L; Gulyás B; Halldin C; Farde L
Meeting abstract: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2009;283(1-2):266

Clinical and non clinical positron emission tomography (PET) studies on vinpocetine, a neuroprotective drug

Vas A; Gulyas B
Editorial comment: NATURE CLINICAL PRACTICE NEUROLOGY. 2008;4(9):470-471

FDG, MET or CHO? The quest for the optimal PET tracer for glioma imaging continues.

Gulyás B; Nyáry I; Borbély K
Letter: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2007;263(1-2):232-233

Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas -: Reply

Borbely K; Toth M; Nyary I; Ericson K; Gulyas B
Editorial comment: SCIENCE AND ENGINEERING ETHICS. 2006;12(4):731-793

The Budapest Meeting 2005 intensified networking on ethics of science: the case of reproductive cloning, germline gene therapy and human dignity.

Van Steendam G; Dinnyés A; Mallet J; Meloni R; Casabona CR; González JG; Kure J; Szathmáry E; Vorstenbosch J; Molnár P; Edbrooke D; Sándor J; Oberfrank F; Cole-Turner R; Hargittai I; Littig B; Ladikas M; Mordini E; Roosendaal HE; Salvi M; Gulyás B; Malpede D
Meeting abstract: NEUROIMAGE. 2006;31:T86

A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635

Cselenyi Z; Olsson H; Halldin C; Gulyas B; Farde L
Meeting abstract: NEUROIMAGE. 2006;31:T85

Increasing the accuracy of in vivo quantification of dopamine-D2/D3 receptor binding in the human brain by partial volume effect correction

Sovago J; Farde L; Cervenka S; Halldin C; Gulyas B
Meeting abstract: NEUROIMAGE. 2006;31:T15

A new PET radioligand [11C]cyclopropyl-FLB 457 for imaging extrastriatal dopamine D2 receptors:: Evaluation in monkey and comparison to [11C]FLB 457 and [11C]Fallypride

Airaksinen AJ; Finnema SJ; Nag S; Mukherjee J; Gulyas B; Halldin C
Meeting abstract: NEUROIMAGE. 2006;31:T120

Dopamine D2/D3 receptor occupancy of apomorphine evaluated with the agonist radioligand [11C]MNPA and the antagonist radioligand [11C]Raclopride.: A PET evaluation in the non-human primate brain

Finnema S; Bang-Andersen B; Farde L; Gulyas B; Wikstrom HV; Halldin C
Meeting abstract: NEUROIMAGE. 2006;31:T114

PET evaluation of the partial dopamine D1 receptor agonist radioligands R- and S-[11C]N-methyl-NNC 01-0259

Finnema S; Bang-Andersen B; Farde L; Jorgensen M; Gulyas B; Foged C; Wikstrom HV; Halldin C
Meeting abstract: NEUROIMAGE. 2006;31:T50

Synthesis and in vivo evaluation of a new PET radioligand for imaging the cannabinoid type-1 (CB1) receptors

Donohue S; Halldin C; Finnema S; Gulyas B; Pike V
Meeting abstract: NEUROIMAGE. 2006;31:T48

Synthesis of ¹¹C-labeled (S,S)-CFMME and (R)-OHDMI and their evaluation as candidate radioligands for imaging norepinephrine transporters with PET

Schou M; Pike VW; Sovago J; Gulyas B; Gallagher P; Dobson D; Walter MW; Rudyk H; Farde L; Halldin C
Meeting abstract: NEUROIMAGE. 2006;31:T28

Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion:: A PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2

Seneca N; Gulyas B; Varrone A; Schou M; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Review: MEDICINAL RESEARCH REVIEWS. 2005;25(6):737-757

Eburnamine derivatives and the brain.

Vas A; Gulyás B
Published conference paper: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2005;229-230:275-284

Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.

Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B
Published conference paper: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2005;229-230:219-223

[11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies.

Gulyás B; Halldin C; Vas A; Banati RB; Shchukin E; Finnema S; Tarkainen J; Tihanyi K; Szilágyi G; Farde L
Review: ERNST SCHERING RESEARCH FOUNDATION WORKSHOP. 2004;(48):95-109

PET for drug development.

Halldin C; Gulyás B; Farde L
Review: NEUROREPORT. 2003;14(8):1097-1106

Four facets of a single brain: behaviour, cerebral blood flow/metabolism, neuronal activity and neurotransmitter dynamics.

Kéri S; Gulyás B
Editorial comment: NEUROREPORT. 2002;13(17):2167-2168

Monkeys--a great asset to reveal human cognitive functions.

Gulyás B; Szathmáry E
Published conference paper: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2002;203-204:259-262

Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.

Vas A; Gulyás B; Szabó Z; Bönöczk P; Csiba L; Kiss B; Kárpáti E; Pánczél G; Nagy Z
Review: CURRENT PHARMACEUTICAL DESIGN. 2001;7(18):1907-1929

PET studies with carbon-11 radioligands in neuropsychopharmacological drug development.

Halldin C; Gulyás B; Farde L
Review: BRAIN RESEARCH REVIEWS. 2001;38(1-2):149-164

An overview on functional receptor autoradiography using [35S]GTPgammaS.

Sóvágó J; Dupuis DS; Gulyás B; Hall H
Editorial comment: NEUROREPORT. 2001;12(8):A49

Personality trait and disposition-a new opening for functional neuroimaging.

Gulyás B
Review: QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2001;45(2):139-152

Brain radioligands--state of the art and new trends.

Halldin C; Gulyás B; Langer O; Farde L
Review: BRAIN RESEARCH BULLETIN. 2000;53(3):245-254

Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.

Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A
Editorial comment: NEUROREPORT. 2000;11(3):i-ii

'Overlearning'--vista into the nature of conscious processes.

Gulyás B
Editorial comment: NEUROREPORT. 1999;10(9):I-II

The dynamics of cortical networks in the human brain

Gulyás B
Review: ORVOSI HETILAP. 1996;137(14):731-738

[Positron emission tomography: foundations and applications].

Gulyás B; Trón L; Csiba L; Esik O; Pálinkás J; Szabó Z
Visa fler

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI